Daniel Compagno
Buenos Aires, C, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Inhibition of galectins in cancer: Biological challenges for their clinical application.
Journal: Frontiers in immunology
Published: November 21, 2022
Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure.
Journal: Cancers
Published: July 17, 2021
Polyfunctional KLRG-1+CD57+ Senescent CD4+ T Cells Infiltrate Tumors and Are Expanded in Peripheral Blood From Breast Cancer Patients.
Journal: Frontiers in immunology
Published: May 21, 2021
Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome.
Journal: Journal for immunotherapy of cancer
Published: November 18, 2020
Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity.
Journal: Frontiers in immunology
Published: June 09, 2018
Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 01, 2018
In Vivo Hemin Conditioning Targets the Vascular and Immunologic Compartments and Restrains Prostate Tumor Development.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 12, 2017
Regulation of galectins by hypoxia and their relevance in angiogenesis: strategies and methods.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 26, 2014
Study of galectins in tumor immunity: strategies and methods.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 26, 2014
Glycans and galectins in prostate cancer biology, angiogenesis and metastasis.
Journal: Glycobiology
Published: June 19, 2014
Last Updated: 09/26/2026